The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2006

Filed:

Feb. 23, 2004
Applicants:

Lioudmila Tchistiakova, Laval, CA;

Shengmin LI, Laval, CA;

Grzegorz Pietrzynski, Montreal, CA;

Valery Alakhov, Baie d'Urfe, CA;

Inventors:

Lioudmila Tchistiakova, Laval, CA;

Shengmin Li, Laval, CA;

Grzegorz Pietrzynski, Montreal, CA;

Valery Alakhov, Baie d'Urfe, CA;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/04 (2006.01); C07K 7/00 (2006.01); A61K 47/00 (2006.01); C07K 5/00 (2006.01); C07K 4/00 (2006.01); C07K 17/00 (2006.01); C07K 9/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to compositions comprised of a peptide ligand or derivatives thereof that are capable of specific binding to the high affinity receptor-1 of vascular endothelial growth factor (VEGF) and structure similar receptors. The invention further provides a peptide ligand or derivatives thereof that are capable of inhibiting angiogenesis induced by VEGF. The present invention also provides a method for treatment or diagnosis of disease associated with angiogenesis in a patient in need of therapy comprising administering to the patient an effective amount of the pharmaceutical composition of the present invention and a pharmaceutical acceptable carrier.


Find Patent Forward Citations

Loading…